Keluarga merupakan sasaran dasar dalam pemeliharaan kesehatan masyarakat untuk mencapai kesehatan nasional di Indonesia. Informasi ditemukan bahwa dalam keluarga wilayah kota Bandung terdapat permasalahan penyakit degeneratif (hipertensi) di keluarga. Tujuan kegiatan ini adalah mengaplikasikan proyek promosi dan preventif kesehatan berbasis kolaborasi antar profesi (interprofessional education) tentang promosi kesehatan hipertensi pada keluarga wilayah kota Bandung. Metode yang digunakan yaitu pemaparan materi, diskusi dan evaluasi kegiatan. Hasil dari pelaksanaan kegiatan ini terjadi peningkatan pengetahuan keluarga tentang hipertensi dari kurang baik menjadi baik dan pengetahuan keluarga tentang pemanfaatan TOGA untuk mengatasi hipertensi. Perlunya sosialisasi secara berkala secara berkala dan melibatkan banyak masyarakat dan kader. Keluarga diharapkan mengaplikasikan dirumah dan disebar luaskan informasi terkait hipertensi dan TOGA untuk hipertensi.

The emergence of Coronavirus Disease 2019 (Covid-19) first occurred in Wuhan, China in December 2019, this virus was caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The increasing number of Covid-19 cases can be seen from the example of a village in the city of Bandung, namely Cimekar Village which has recorded 50 cases with the impact of 1 person dying, 1 person being treated and 48 people doing self-isolation (ISOMAN). Judging from the many cases of self-isolation in Cimekar Village, therefore, the author wants to conduct a study on public knowledge of how to treat Covid-19 with pharmacological therapy. In this scientific paper, the writing method that the author uses is a comparative study in which the author gives a pretest, then delivers a webinar with the title Covid-19 Pharmacological Therapy to Isoman patients, without symptoms and mild symptoms. After that, we did a pretest and posttest. Activities are documented and published through mass media, social media and journal articles. Webinar results and written test evaluations increase Knowledge and understanding of the application of Covid-19 pharmacological therapy. The average value for the pretest is 7.97 and the average value for the posttest is 8.06 from the average result, the partners experience a change in value or increase in value where the posttest average value is 8.06. Counseling with the application of Covid-19 pharmacological therapy in Cimekar Village can increase knowledge of how to apply therapy to Covid-19 patients with mild and asymptomatic symptoms, this is expected to be an impetus for changes in community behavior in handling Covid-19.

Long-term therapy is needed for all chronic diseases such as Diabetes Mellitus (DM) so that it can affect the quality of life. Various characteristic factors can affect the quality of life such as socio-demographic and clinical. This study aims to obtain an overview of patient characteristics and analyze characteristic factors that can affect the quality of life of Prolanis type 2 DM patients at several Bandung City Public Health Care from February to May 2019. A total of 116 patients met the inclusion criteria as the study sample. The instrument used is a Diabetes Quality of Life Clinical Trial Questionnaire (DQLCTQ) in Indonesian with a cross-sectional method. The results of the description of patient characteristics are more women, age 63 years, not working, education high school, marital status, not smoking, moderate-severe physical activity, comorbidities, duration of DM < 6 years, and fasting blood glucose levels >126 mg/dL. The results of the analysis using the Mann-Whitney test showed that the difference in the quality of life with characteristic factors is not significantly different (p>0.05) and the results of the analysis with linear regression showed that there were no factors that affected the quality of life.

Pneumonia is an infection caused by microorganisms. It is characterized by inflammation of the lung parenchyma. Most of inpatients with pneumonia get more than five drugs. It causes increase the risk of potential drug-drug interactions. Drug interactions can cause adverse drug reactions. The purpose of this study is to identify potential drug-drug interactions and to determine the prevalence and risk of potential drug-drug interactions. This research is cross-sectional study with retrospective data collection. Data retrieval from medical records of pneumonia patients at a hospital in Bandung from January to December 2018. They are 480 potential drug-drug interactions that can be identified. The interactions included 261 major interactions (54.38%), 214 moderate interactions (44.58%), and 5 minor interactions (1.04%). From total of 402 patients, 48.51% of patients experienced potential drug-drug interactions. There is a significant relationship between the number of drugs and the potential drug-drug interactions (p-value < 0,05). Patients who received > 6 drugs have 10,1 times higher risk of potential drug-drug interactions than those who received < 6 drugs (95% CI 6,0-16,9).